CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Grant or award Director acquired 29,205 shares (grant or award)
- 4 Grant or award Director acquired 29,205 shares (grant or award)
- 4 Grant or award Director acquired 29,205 shares (grant or award)
- 4 Grant or award Director acquired 29,205 shares (grant or award)
- 4 Grant or award Director acquired 29,205 shares (grant or award)
- 4 Grant or award Director acquired 29,205 shares (grant or award)
- 4 Grant or award Director acquired 29,205 shares (grant or award)
- 4 Grant or award Director acquired 29,205 shares (grant or award)
- 4 Grant or award Director acquired 848 shares (grant or award)
- 4 Grant or award Director acquired 4,110 shares (grant or award)
- 4 Grant or award Director acquired 7,716 shares (grant or award)
- 4 Grant or award Director acquired 3,684 shares (grant or award)
- 4 Grant or award Director acquired 3,642 shares (grant or award)
- 4/A Open-market sale EVP, General Counsel sold 1,275 shares at an average $9.27 ($11,824)
- 4 Shares withheld for taxes EVP, General Counsel gave up 11,069 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 27,607 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 4,001 shares (to pay taxes)
- 4 Grant or award SVP, Controller & CAO acquired 25,266 shares (grant or award)
- 4 Open-market sale EVP, General Counsel sold 292 shares at $9.32 ($2,721)
- 4 Shares withheld for taxes Chief Executive Officer gave up 6,327 shares (to pay taxes)
Page 8 of 61 · 1,214 filings